Neural control of energy balance: Translating circuits to therapies

Cell

Volumn 161, Issue 1, 2015, Pages 133-145

  Gautron, Laurent ^a   Elmquist, Joel K ^a,b   Williams, Kevin W ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE PLUS NALTREXONE; ANOREXIGENIC AGENT; DEXFENFLURAMINE; EXENDIN 4; FENFLURAMINE; GLUCOSE; INTERMEDIN; LEPTIN RECEPTOR; LIRAGLUTIDE; LORCASERIN; MELANOCORTIN; METFORMIN; METRELEPTIN; PHENTERMINE; PRAMLINTIDE; RIMONABANT; SIBUTRAMINE;

ARTICLE; CALORIC INTAKE; DIABETES MELLITUS; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; ANIMAL; BRAIN; DIABETES COMPLICATIONS; DRUG EFFECTS; ENERGY METABOLISM; METABOLISM; NERVE TRACT; PATHOPHYSIOLOGY;

ANIMALS; APPETITE DEPRESSANTS; BRAIN; DIABETES COMPLICATIONS; ENERGY METABOLISM; HUMANS; NEURAL PATHWAYS; OBESITY;

EID: 84925841979     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.02.023     Document Type: Review

References (149)

1. A.C. Adams, and A. Kharitonenkov FGF21: The center of a transcriptional nexus in metabolic regulation Curr. Diabetes Rev. 8 2012 285 293
2. R.S. Ahima, and J.S. Flier Leptin Annu. Rev. Physiol. 62 2000 413 437
3. D.B. Allison, K.M. Gadde, W.T. Garvey, C.A. Peterson, M.L. Schwiers, T. Najarian, P.Y. Tam, B. Troupin, and W.W. Day Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP) Obesity (Silver Spring) 20 2012 330 342
4. Y. Aponte, D. Atasoy, and S.M. Sternson AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training Nat. Neurosci. 14 2011 351 355
5. M. Asai, S. Ramachandrappa, M. Joachim, Y. Shen, R. Zhang, N. Nuthalapati, V. Ramanathan, D.E. Strochlic, P. Ferket, and K. Linhart et al. Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity Science 341 2013 275 278
6. A. Astrup, I. Caterson, P. Zelissen, B. Guy-Grand, M. Carruba, B. Levy, X. Sun, and M. Fitchet Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects Obes. Res. 12 2004 1658 1669
7. A. Astrup, S. Rössner, L. Van Gaal, A. Rissanen, L. Niskanen, M. Al Hakim, J. Madsen, M.F. Rasmussen, M.E. Lean, N.N.S. Group NN8022-1807 Study Group Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study Lancet 374 2009 1606 1616
8. D. Atasoy, J.N. Betley, H.H. Su, and S.M. Sternson Deconstruction of a neural circuit for hunger Nature 488 2012 172 177
9. G.S. Barsh, I.S. Farooqi, and S. O'Rahilly Genetics of body-weight regulation Nature 404 2000 644 651
10. T.J. Bartness, Y. Liu, Y.B. Shrestha, and V. Ryu Neural innervation of white adipose tissue and the control of lipolysis Front. Neuroendocrinol. 35 2014 473 493
11. E.D. Berglund, C. Liu, J.W. Sohn, T. Liu, M.H. Kim, C.E. Lee, C.R. Vianna, K.W. Williams, Y. Xu, and J.K. Elmquist Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis J. Clin. Invest. 123 2013 5061 5070
12. E.D. Berglund, T. Liu, X. Kong, J.W. Sohn, L. Vong, Z. Deng, C.E. Lee, S. Lee, K.W. Williams, and D.P. Olson et al. Melanocortin 4 receptors in autonomic neurons regulate thermogenesis and glycemia Nat. Neurosci. 17 2014 911 913
13. H.R. Berthoud, and W.L. Neuhuber Functional and chemical anatomy of the afferent vagal system Auton. Neurosci. 85 2000 1 17
14. P.S. Boggio, E.C. de Macedo, J.S. Schwartzman, D. Brunoni, M.C. Teixeira, and F. Fregni Transcranial direct current stimulation: a novel approach to control hyperphagia in Prader-Willi syndrome J. Child Neurol. 24 2009 642 643
15. A.L. Bookout, M.H. de Groot, B.M. Owen, S. Lee, L. Gautron, H.L. Lawrence, X. Ding, J.K. Elmquist, J.S. Takahashi, D.J. Mangelsdorf, and S.A. Kliewer FGF21 regulates metabolism and circadian behavior by acting on the nervous system Nat. Med. 19 2013 1147 1152
16. C.M. Borg, C.W. le Roux, M.A. Ghatei, S.R. Bloom, A.G. Patel, and S.J. Aylwin Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety Br. J. Surg. 93 2006 210 215
17. G.A. Bray Medications for obesity: mechanisms and applications Clin. Chest Med. 30 2009 525 538, ix
18. G.A. Bray Medical treatment of obesity: the past, the present and the future Best Pract. Res. Clin. Gastroenterol. 28 2014 665 684
19. K.N. Browning, S.R. Fortna, and A. Hajnal Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones J. Physiol. 591 2013 2357 2372
20. J.M. Bruce, L. Hancock, A. Bruce, R.J. Lepping, L. Martin, J.D. Lundgren, S. Malley, L.M. Holsen, and C.R. Savage Changes in brain activation to food pictures after adjustable gastric banding Surg. Obes. Relat. Dis. 8 2012 602 608
21. H. Buchwald Revisional metabolic/bariatric surgery: a moral obligation Obes. Surg. 25 2014 547 549
22. M. Camilleri, J. Toouli, M.F. Herrera, B. Kulseng, L. Kow, J.P. Pantoja, R. Marvik, G. Johnsen, C.J. Billington, and F.G. Moody et al. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device Surgery 143 2008 723 731
23. A.P. Chambers, H.E. Wilson-Perez, S. McGrath, B.E. Grayson, K.K. Ryan, D.A. D'Alessio, S.C. Woods, D.A. Sandoval, and R.J. Seeley Effect of vertical sleeve gastrectomy on food selection and satiation in rats Am. J. Physiol. Endocrinol. Metab. 303 2012 E1076 E1084
24. J.T. Clark, P.S. Kalra, W.R. Crowley, and S.P. Kalra Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats Endocrinology 115 1984 427 429
25. C. Clemmensen, J. Chabenne, B. Finan, L. Sullivan, K. Fischer, D. Küchler, L. Sehrer, T. Ograjsek, S.M. Hofmann, and S.C. Schriever et al. GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet Diabetes 63 2014 1422 1427
26. D. Cohen European drugs agency clashes with scientists over safety of GLP-1 drugs BMJ 347 2013 f4838
27. J.L. Colquitt, K. Pickett, E. Loveman, and G.K. Frampton Surgery for weight loss in adults Cochrane Database Syst. Rev. 8 2014 CD003641
28. R.D. Cone Anatomy and regulation of the central melanocortin system Nat. Neurosci. 8 2005 571 578
29. H.M. Connolly, J.L. Crary, M.D. McGoon, D.D. Hensrud, B.S. Edwards, W.D. Edwards, and H.V. Schaff Valvular heart disease associated with fenfluramine-phentermine N. Engl. J. Med. 337 1997 581 588
30. R.V. Considine, and J.F. Caro Leptin in humans: current progress and future directions Clin. Chem. 42 1996 843 844
31. D. Cota, M.H. Tschöp, T.L. Horvath, and A.S. Levine Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res. Brain Res. Rev. 51 2006 85 107
32. A. Czupryn, Y.D. Zhou, X. Chen, D. McNay, M.P. Anderson, J.S. Flier, and J.D. Macklis Transplanted hypothalamic neurons restore leptin signaling and ameliorate obesity in db/db mice Science 334 2011 1133 1137
33. J.W. Day, N. Ottaway, J.T. Patterson, V. Gelfanov, D. Smiley, J. Gidda, H. Findeisen, D. Bruemmer, D.J. Drucker, and N. Chaudhary et al. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents Nat. Chem. Biol. 5 2009 749 757
34. E. Dayan, N. Censor, E.R. Buch, M. Sandrini, and L.G. Cohen Noninvasive brain stimulation: from physiology to network dynamics and back Nat. Neurosci. 16 2013 838 844
35. G. de Lartigue, C.B. de La Serre, and H.E. Raybould Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin Physiol. Behav. 105 2011 100 105
36. K. Deisseroth Optogenetics and psychiatry: applications, challenges, and opportunities Biol. Psychiatry 71 2012 1030 1032
37. G.T. Dodd, S. Decherf, K. Loh, S.E. Simonds, F. Wiede, E. Balland, T.L. Merry, H. Münzberg, Z.Y. Zhang, and B.B. Kahn et al. Leptin and insulin act on POMC neurons to promote the browning of white fat Cell 160 2015 88 104
38. D.J. Drucker Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes Curr. Pharm. Des. 7 2001 1399 1412
39. D.J. Drucker The biology of incretin hormones Cell Metab. 3 2006 153 165
40. K. Famm, B. Litt, K.J. Tracey, E.S. Boyden, and M. Slaoui Drug discovery: a jump-start for electroceuticals Nature 496 2013 159 161
41. S. Fang, J.M. Suh, S.M. Reilly, E. Yu, O. Osborn, D. Lackey, E. Yoshihara, A. Perino, S. Jacinto, and Y. Lukasheva et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance Nat. Med. 21 2015 159 165
42. I.S. Farooqi, and S. O'Rahilly Monogenic obesity in humans Annu. Rev. Med. 56 2005 443 458
43. H.L. Fehm, R. Smolnik, W. Kern, G.P. McGregor, U. Bickel, and J. Born The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans J. Clin. Endocrinol. Metab. 86 2001 1144 1148
44. B. Finan, B. Yang, N. Ottaway, K. Stemmer, T.D. Müller, C.X. Yi, K. Habegger, S.C. Schriever, C. García-Cáceres, and D.G. Kabra et al. Targeted estrogen delivery reverses the metabolic syndrome Nat. Med. 18 2012 1847 1856
45. F. Fregni, F. Orsati, W. Pedrosa, S. Fecteau, F.A. Tome, M.A. Nitsche, T. Mecca, E.C. Macedo, A. Pascual-Leone, and P.S. Boggio Transcranial direct current stimulation of the prefrontal cortex modulates the desire for specific foods Appetite 51 2008 34 41
46. T. Fujikawa, E.D. Berglund, V.R. Patel, G. Ramadori, C.R. Vianna, L. Vong, F. Thorel, S. Chera, P.L. Herrera, and B.B. Lowell et al. Leptin engages a hypothalamic neurocircuitry to permit survival in the absence of insulin Cell Metab. 18 2013 431 444
47. G. Gaich, J.Y. Chien, H. Fu, L.C. Glass, M.A. Deeg, W.L. Holland, A. Kharitonenkov, T. Bumol, H.K. Schilske, and D.E. Moller The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes Cell Metab. 18 2013 333 340
48. A.J. Garber, T.G. Duncan, A.M. Goodman, D.J. Mills, and J.L. Rohlf Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial Am. J. Med. 103 1997 491 497
49. W.T. Garvey, D.H. Ryan, M. Look, K.M. Gadde, D.B. Allison, C.A. Peterson, M. Schwiers, W.W. Day, and C.H. Bowden Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study Am. J. Clin. Nutr. 95 2012 297 308
50. O. Gavrilova, B. Marcus-Samuels, D. Graham, J.K. Kim, G.I. Shulman, A.L. Castle, C. Vinson, M. Eckhaus, and M.L. Reitman Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice J. Clin. Invest. 105 2000 271 278
51. J.R. Greenfield, J.W. Miller, J.M. Keogh, E. Henning, J.H. Satterwhite, G.S. Cameron, B. Astruc, J.P. Mayer, S. Brage, and T.C. See et al. Modulation of blood pressure by central melanocortinergic pathways N. Engl. J. Med. 360 2009 44 52
52. F.L. Greenway, E. Dunayevich, G. Tollefson, J. Erickson, M. Guttadauria, K. Fujioka, M.A. Cowley, N.B.S. Group NB-201 Study Group Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo J. Clin. Endocrinol. Metab. 94 2009 4898 4906
53. L.K. Heisler, M.A. Cowley, T. Kishi, L.H. Tecott, W. Fan, M.J. Low, J.L. Smart, M. Rubinstein, J. Tatro, and J.M. Zigman et al. Central serotonin and melanocortin pathways regulating energy homeostasis Ann. N Y Acad. Sci. 994 2003 169 174
54. K. Herrmann, K. Shan, S.C. Brunell, and S. Chen Effects of pramlintide in patients with type 2 diabetes mellitus: an analysis using daily insulin dose tertiles Endocr. Pract. 20 2014 1070 1075
55. M. Horowitz, A. Flint, K.L. Jones, C. Hindsberger, M.F. Rasmussen, C. Kapitza, S. Doran, T. Jax, M. Zdravkovic, and I.M. Chapman Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes Diabetes Res. Clin. Pract. 97 2012 258 266
56. K. Hunter, and C. Hölscher Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis BMC Neurosci. 13 2012 33
57. S. Ikramuddin, R.P. Blackstone, A. Brancatisano, J. Toouli, S.N. Shah, B.M. Wolfe, K. Fujioka, J.W. Maher, J. Swain, and F.G. Que et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial JAMA 312 2014 915 922
58. V.M. Jackson, D.A. Price, and P.A. Carpino Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies Expert Opin. Investig. Drugs 23 2014 1055 1066
59. E.D. Javor, E.K. Cochran, C. Musso, J.R. Young, A.M. Depaoli, and P. Gorden Long-term efficacy of leptin replacement in patients with generalized lipodystrophy Diabetes 54 2005 1994 2002
60. C.B. Juhl, M. Hollingdal, J. Sturis, G. Jakobsen, H. Agerso, J. Veldhuis, N. Porksen, and O. Schmitz Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes Diabetes 51 2002 424 429
61. D. Julius, A.B. MacDermott, T.M. Jessel, K. Huang, S. Molineaux, I. Schieren, and R. Axel Functional expression of the 5-HT1c receptor in neuronal and nonneuronal cells Cold Spring Harb. Symp. Quant. Biol. 53 1988 385 393
62. S. Kentish, H. Li, L.K. Philp, T.A. O'Donnell, N.J. Isaacs, R.L. Young, G.A. Wittert, L.A. Blackshaw, and A.J. Page Diet-induced adaptation of vagal afferent function J. Physiol. 590 2012 209 221
63. P. Kievit, H. Halem, D.L. Marks, J.Z. Dong, M.M. Glavas, P. Sinnayah, L. Pranger, M.A. Cowley, K.L. Grove, and M.D. Culler Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques Diabetes 62 2013 490 497
64. M.J. Krashes, S. Koda, C. Ye, S.C. Rogan, A.C. Adams, D.S. Cusher, E. Maratos-Flier, B.L. Roth, and B.B. Lowell Rapid, reversible activation of AgRP neurons drives feeding behavior in mice J. Clin. Invest. 121 2011 1424 1428
65. M.J. Krashes, B.P. Shah, S. Koda, and B.B. Lowell Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP Cell Metab. 18 2013 588 595
66. M.J. Krashes, B.P. Shah, J.C. Madara, D.P. Olson, D.E. Strochlic, A.S. Garfield, L. Vong, H. Pei, M. Watabe-Uchida, and N. Uchida et al. An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger Nature 507 2014 238 242
67. A. Laurenius, I. Larsson, M. Bueter, K.J. Melanson, I. Bosaeus, H.B. Forslund, H. Lönroth, L. Fändriks, and T. Olbers Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypass Int J Obes (Lond) 36 2012 348 355
68. G.M. Leinninger, Y.H. Jo, R.L. Leshan, G.W. Louis, H. Yang, J.G. Barrera, H. Wilson, D.M. Opland, M.A. Faouzi, and Y. Gong et al. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding Cell Metab. 10 2009 89 98
69. J.W. Lichtman, J. Livet, and J.R. Sanes A technicolour approach to the connectome Nat. Rev. Neurosci. 9 2008 417 422
70. J. Licinio, S. Caglayan, M. Ozata, B.O. Yildiz, P.B. de Miranda, F. O'Kirwan, R. Whitby, L. Liang, P. Cohen, and S. Bhasin et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults Proc. Natl. Acad. Sci. USA 101 2004 4531 4536
71. E. Lo Menzo, S. Szomstein, and R.J. Rosenthal Changing trends in bariatric surgery Scand. J. Surg. 104 2014 18 23
72. T.A. Lutz, and M. Bueter Physiological mechanisms behind Roux-en-Y gastric bypass surgery Dig. Surg. 31 2014 13 24
73. S. Madsbad, O. Schmitz, J. Ranstam, G. Jakobsen, D.R. Matthews, N.N.I.S. Group NN2211-1310 International Study Group Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial Diabetes Care 27 2004 1335 1342
74. C.K. Martin, L.M. Redman, J. Zhang, M. Sanchez, C.M. Anderson, S.R. Smith, and E. Ravussin Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure J. Clin. Endocrinol. Metab. 96 2011 837 845
75. J. McGuirk, E. Goodall, T. Silverstone, and P. Willner Differential effects of d-fenfluramine, l-fenfluramine and d-amphetamine on the microstructure of human eating behaviour Behav. Pharmacol. 2 1991 113 119
76. R.A. Montenegro, A.H. Okano, F.A. Cunha, J.L. Gurgel, E.B. Fontes, and P.T. Farinatti Prefrontal cortex transcranial direct current stimulation associated with aerobic exercise change aspects of appetite sensation in overweight adults Appetite 58 2012 333 338
77. J.D. Mul, D.P. Begg, J.G. Barrera, B. Li, E.K. Matter, D.A. D'Alessio, S.C. Woods, R.J. Seeley, and D.A. Sandoval High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 2013 R68 R77
78. M.G. Myers Jr., and D.P. Olson Central nervous system control of metabolism Nature 491 2012 357 363
79. J. Nedergaard, and B. Cannon The browning of white adipose tissue: some burning issues Cell Metab. 20 2014 396 407
80. K. Nonogaki, A.M. Strack, M.F. Dallman, and L.H. Tecott Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene Nat. Med. 4 1998 1152 1156
81. P.M. O'Neil, S.R. Smith, N.J. Weissman, M.C. Fidler, M. Sanchez, J. Zhang, B. Raether, C.M. Anderson, and W.R. Shanahan Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study Obesity (Silver Spring) 20 2012 1426 1436
82. S. Obici, and L. Rossetti Minireview: nutrient sensing and the regulation of insulin action and energy balance Endocrinology 144 2003 5172 5178
83. E.A. Oral, V. Simha, E. Ruiz, A. Andewelt, A. Premkumar, P. Snell, A.J. Wagner, A.M. DePaoli, M.L. Reitman, and S.I. Taylor et al. Leptin-replacement therapy for lipodystrophy N. Engl. J. Med. 346 2002 570 578
84. M.P. Ostlund, O. Backman, R. Marsk, D. Stockeld, J. Lagergren, F. Rasmussen, and E. Näslund Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery JAMA Surg. 148 2013 374 377
85. B.M. Owen, X. Ding, D.A. Morgan, K.C. Coate, A.L. Bookout, K. Rahmouni, S.A. Kliewer, and D.J. Mangelsdorf FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss Cell Metab. 20 2014 670 677
86. J.V. Pardo, S.A. Sheikh, M.A. Kuskowski, C. Surerus-Johnson, M.C. Hagen, J.T. Lee, B.R. Rittberg, and D.E. Adson Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation Int J Obes (Lond) 31 2007 1756 1759
87. M.A. Pelleymounter, M.J. Cullen, M.B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins Effects of the obese gene product on body weight regulation in ob/ob mice Science 269 1995 540 543
88. R.J. Perry, V.T. Samuel, K.F. Petersen, and G.I. Shulman The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes Nature 510 2014 84 91
89. K.F. Petersen, E.A. Oral, S. Dufour, D. Befroy, C. Ariyan, C. Yu, G.W. Cline, A.M. DePaoli, S.I. Taylor, P. Gorden, and G.I. Shulman Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy J. Clin. Invest. 109 2002 1345 1350
90. A. Pocai, T.K. Lam, R. Gutierrez-Juarez, S. Obici, G.J. Schwartz, J. Bryan, L. Aguilar-Bryan, and L. Rossetti Hypothalamic K(ATP) channels control hepatic glucose production Nature 434 2005 1026 1031
91. T.L. Powley, M.M. Chi, L.A. Schier, and R.J. Phillips Obesity: should treatments target visceral afferents? Physiol. Behav. 86 2005 698 708
92. E. Ravussin, S.R. Smith, J.A. Mitchell, R. Shringarpure, K. Shan, H. Maier, J.E. Koda, and C. Weyer Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy Obesity (Silver Spring) 17 2009 1736 1743
93. M. Rosenbaum, M. Sy, K. Pavlovich, R.L. Leibel, and J. Hirsch Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli J. Clin. Invest. 118 2008 2583 2591
94. M. Rossi, M.S. Kim, D.G. Morgan, C.J. Small, C.M. Edwards, D. Sunter, S. Abusnana, A.P. Goldstone, S.H. Russell, and S.A. Stanley et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo Endocrinology 139 1998 4428 4431
95. J.D. Roth, J.L. Trevaskis, J. Wilson, C. Lei, J. Athanacio, C. Mack, N.C. Kesty, T. Coffey, C. Weyer, and D.G. Parkes Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats Int. J. Obes. (Lond.) 32 2008 1201 1210
96. H.B. Ruan, M.O. Dietrich, Z.W. Liu, M.R. Zimmer, M.D. Li, J.P. Singh, K. Zhang, R. Yin, J. Wu, T.L. Horvath, and X. Yang O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat Cell 159 2014 306 317
97. K.K. Ryan, V. Tremaroli, C. Clemmensen, P. Kovatcheva-Datchary, A. Myronovych, R. Karns, H.E. Wilson-Pérez, D.A. Sandoval, R. Kohli, F. Bäckhed, and R.J. Seeley FXR is a molecular target for the effects of vertical sleeve gastrectomy Nature 509 2014 183 188
98. M.G. Sarr, C.J. Billington, R. Brancatisano, A. Brancatisano, J. Toouli, L. Kow, N.T. Nguyen, R. Blackstone, J.W. Maher, S. Shikora EMPOWER Study Group The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity Obes. Surg. 22 2012 1771 1782
99. D.A. Sarruf, J.P. Thaler, G.J. Morton, J. German, J.D. Fischer, K. Ogimoto, and M.W. Schwartz Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats Diabetes 59 2010 1817 1824
100. P.R. Schauer, B. Burguera, S. Ikramuddin, D. Cottam, W. Gourash, G. Hamad, G.M. Eid, S. Mattar, R. Ramanathan, and E. Barinas-Mitchel et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus Ann. Surg. 238 2003 467 484 discussion 84-85
101. M.W. Schwartz, and D. Porte Jr. Diabetes, obesity, and the brain Science 307 2005 375 379
102. M.W. Schwartz, R.J. Seeley, S.C. Woods, D.S. Weigle, L.A. Campfield, P. Burn, and D.G. Baskin Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus Diabetes 46 1997 2119 2123
103. M.M. Scott, K.W. Williams, J. Rossi, C.E. Lee, and J.K. Elmquist Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice J. Clin. Invest. 121 2011 2413 2421
104. J.A. Sebag, C. Zhang, P.M. Hinkle, A.M. Bradshaw, and R.D. Cone Developmental control of the melanocortin-4 receptor by MRAP2 proteins in zebrafish Science 341 2013 278 281
105. A. Secher, J. Jelsing, A.F. Baquero, J. Hecksher-Sorensen, M.A. Cowley, L.S. Dalboge, G. Hansen, K.L. Grove, C. Pyke, and K. Raun et al. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss J. Clin. Invest. 124 2014 4473 4488
106. R.J. Seeley, and M. Tschöp How diabetes went to our heads Nat. Med. 12 2006 47 49 discussion 49
107. S. Shikora, J. Toouli, M.F. Herrera, B. Kulseng, H. Zulewski, R. Brancatisano, L. Kow, J.P. Pantoja, G. Johnsen, and A. Brancatisano et al. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus J. Obes. 2013 2013 245683
108. I. Shimomura, R.E. Hammer, S. Ikemoto, M.S. Brown, and J.L. Goldstein Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy Nature 401 1999 73 76
109. A.C. Shin, H. Zheng, R.L. Townsend, L.M. Patterson, G.M. Holmes, and H.R. Berthoud Longitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in high-fat-fed obese rats Obes. Surg. 23 2013 531 540
110. S. Sisley, R. Gutierrez-Aguilar, M. Scott, D.A. D'Alessio, D.A. Sandoval, and R.J. Seeley Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect J. Clin. Invest. 124 2014 2456 2463
111. K.P. Skibicka, and H.J. Grill Hindbrain leptin stimulation induces anorexia and hyperthermia mediated by hindbrain melanocortin receptors Endocrinology 150 2009 1705 1711
112. S.R. Smith, N.J. Weissman, C.M. Anderson, M. Sanchez, E. Chuang, S. Stubbe, H. Bays, W.R. Shanahan, M. Behavioral Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group Multicenter, placebo-controlled trial of lorcaserin for weight management N. Engl. J. Med. 363 2010 245 256
113. J.W. Sohn, L.E. Harris, E.D. Berglund, T. Liu, L. Vong, B.B. Lowell, N. Balthasar, K.W. Williams, and J.K. Elmquist Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons Cell 152 2013 612 619
114. M.L. Soto-Montenegro, J. Pascau, and M. Desco Response to deep brain stimulation in the lateral hypothalamic area in a rat model of obesity: in vivo assessment of brain glucose metabolism Mol. Imaging Biol. 16 2014 830 837
115. K.E. Steele, G.P. Prokopowicz, M.A. Schweitzer, T.H. Magunsuon, A.O. Lidor, H. Kuwabawa, A. Kumar, J. Brasic, and D.F. Wong Alterations of central dopamine receptors before and after gastric bypass surgery Obes. Surg. 20 2010 369 374
116. M.A. Stefater, D. Pérez-Tilve, A.P. Chambers, H.E. Wilson-Pérez, D.A. Sandoval, J. Berger, M. Toure, M. Tschöp, S.C. Woods, and R.J. Seeley Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity Gastroenterology 138 2010 2426 2436 e1-e3
117. M.A. Stefater, H.E. Wilson-Pérez, A.P. Chambers, D.A. Sandoval, and R.J. Seeley All bariatric surgeries are not created equal: insights from mechanistic comparisons Endocr. Rev. 33 2012 595 622
118. J. Suzuki, F. Haimovici, and G. Chang Alcohol use disorders after bariatric surgery Obes. Surg. 22 2012 201 207
119. R.C. Thirlby, F. Bahiraei, J. Randall, and A. Drewnoski Effect of Roux-en-Y gastric bypass on satiety and food likes: the role of genetics J. Gastrointest. Surg. 10 2006 270 277
120. W.J. Thomsen, A.J. Grottick, F. Menzaghi, H. Reyes-Saldana, S. Espitia, D. Yuskin, K. Whelan, M. Martin, M. Morgan, and W. Chen et al. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization J. Pharmacol. Exp. Ther. 325 2008 577 587
121. J.L. Trevaskis, T. Coffey, R. Cole, C. Lei, C. Wittmer, B. Walsh, C. Weyer, J. Koda, A.D. Baron, D.G. Parkes, and J.D. Roth Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms Endocrinology 149 2008 5679 5687
122. S. Troy, M. Soty, L. Ribeiro, L. Laval, S. Migrenne, X. Fioramonti, B. Pillot, V. Fauveau, R. Aubert, and B. Viollet et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice Cell Metab. 8 2008 201 211
123. D.Q. Truong, G. Magerowski, G.L. Blackburn, M. Bikson, and M. Alonso-Alonso Computational modeling of transcranial direct current stimulation (tDCS) in obesity: Impact of head fat and dose guidelines Neuroimage Clin 2 2013 759 766
124. M.D. Turton, D. O'Shea, I. Gunn, S.A. Beak, C.M. Edwards, K. Meeran, S.J. Choi, G.M. Taylor, M.M. Heath, and P.D. Lambert et al. A role for glucagon-like peptide-1 in the central regulation of feeding Nature 379 1996 69 72
125. D.J. Urban, and B.L. Roth DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility Annu. Rev. Pharmacol. Toxicol. 55 2015 399 417
126. D. Val-Laillet, A. Biraben, G. Randuineau, and C.H. Malbert Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs Appetite 55 2010 245 252
127. L.H. Van der Ploeg, A. Kanatani, D. MacNeil, T. Ming Fong, A. Strack, R. Nargund, and X.M. Guan Design and synthesis of (ant)-agonists that alter appetite and adiposity Prog. Brain Res. 153 2006 107 118
128. L.H. Van der Ploeg, W.J. Martin, A.D. Howard, R.P. Nargund, C.P. Austin, X. Guan, J. Drisko, D. Cashen, I. Sebhat, and A.A. Patchett et al. A role for the melanocortin 4 receptor in sexual function Proc. Natl. Acad. Sci. USA 99 2002 11381 11386
129. M.L. Vetter, L.F. Faulconbridge, V.L. Webb, and T.A. Wadden Behavioral and pharmacologic therapies for obesity Nat. Rev. Endocrinol. 6 2010 578 588
130. J.M. Wade, P. Juneja, A.W. MacKay, J. Graham, P.J. Havel, L.H. Tecott, and E.H. Goulding Synergistic impairment of glucose homeostasis in ob/ob mice lacking functional serotonin 2C receptors Endocrinology 149 2008 955 961
131. P. Wellhöner, R. Hörster, F. Jacobs, F. Sayk, H. Lehnert, and C. Dodt Intranasal application of the melanocortin 4 receptor agonist MSH/ACTH(4-10) in humans causes lipolysis in white adipose tissue Int. J. Obes. (Lond.) 36 2012 703 708
132. D.M. Whiting, N.D. Tomycz, J. Bailes, L. de Jonge, V. Lecoultre, B. Wilent, D. Alcindor, E.R. Prostko, B.C. Cheng, and C. Angle et al. Lateral hypothalamic area deep brain stimulation for refractory obesity: a pilot study with preliminary data on safety, body weight, and energy metabolism J. Neurosurg. 119 2013 56 63
133. T. Wichmann, and M.R. Delong Deep brain stimulation for neurologic and neuropsychiatric disorders Neuron 52 2006 197 204
134. J.E. Wikberg, and F. Mutulis Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction Nat. Rev. Drug Discov. 7 2008 307 323
135. K.W. Williams, T. Liu, X. Kong, M. Fukuda, Y. Deng, E.D. Berglund, Z. Deng, Y. Gao, T. Liu, and J.W. Sohn et al. Xbp1s in Pomc neurons connects ER stress with energy balance and glucose homeostasis Cell Metab. 20 2014 471 482
136. H.E. Wilson-Pérez, A.P. Chambers, D.A. Sandoval, M.A. Stefater, S.C. Woods, S.C. Benoit, and R.J. Seeley The effect of vertical sleeve gastrectomy on food choice in rats Int. J Obes. (Lond.) 37 2013 288 295
137. F.L. Wright, and R.J. Rodgers Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash Psychopharmacology (Berl.) 228 2013 291 307
138. Q. Wu, M.P. Boyle, and R.D. Palmiter Loss of GABAergic signaling by AgRP neurons to the parabrachial nucleus leads to starvation Cell 137 2009 1225 1234
139. Q. Wu, M.S. Clark, and R.D. Palmiter Deciphering a neuronal circuit that mediates appetite Nature 483 2012 594 597
140. Y. Xu, J.E. Jones, D. Kohno, K.W. Williams, C.E. Lee, M.J. Choi, J.G. Anderson, L.K. Heisler, J.M. Zigman, B.B. Lowell, and J.K. Elmquist 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis Neuron 60 2008 582 589
141. Y. Xu, E.D. Berglund, J.W. Sohn, W.L. Holland, J.C. Chuang, M. Fukuda, J. Rossi, K.W. Williams, J.E. Jones, and J.M. Zigman et al. 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate insulin sensitivity in liver Nat. Neurosci. 13 2010 1457 1459
142. Y. Xu, J.E. Jones, D.A. Lauzon, J.G. Anderson, N. Balthasar, L.K. Heisler, A.R. Zinn, B.B. Lowell, and J.K. Elmquist A serotonin and melanocortin circuit mediates D-fenfluramine anorexia J. Neurosci. 30 2010 14630 14634
143. H. Yamamoto, C.E. Lee, J.N. Marcus, T.D. Williams, J.M. Overton, M.E. Lopez, A.N. Hollenberg, L. Baggio, C.B. Saper, D.J. Drucker, and J.K. Elmquist Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons J. Clin. Invest. 110 2002 43 52
144. E. Yulyaningsih, L. Zhang, H. Herzog, and A. Sainsbury NPY receptors as potential targets for anti-obesity drug development Br. J. Pharmacol. 163 2011 1170 1202
145. J.F. Zechner, U.L. Mirshahi, S. Satapati, E.D. Berglund, J. Rossi, M.M. Scott, C.D. Still, G.S. Gerhard, S.C. Burgess, T. Mirshahi, and V. Aguirre Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans Gastroenterology 144 2013 580 590, e7
146. C. Zhan, J. Zhou, Q. Feng, J.E. Zhang, S. Lin, J. Bao, P. Wu, and M. Luo Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively J. Neurosci. 33 2013 3624 3632
147. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
148. H. Zheng, and H.R. Berthoud Neural systems controlling the drive to eat: mind versus metabolism Physiology (Bethesda) 23 2008 75 83
149. H. Zheng, A.C. Shin, N.R. Lenard, R.L. Townsend, L.M. Patterson, D.L. Sigalet, and H.R. Berthoud Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery Am. J. Physiol. Regul. Integr. Comp. Physiol. 297 2009 R1273 R1282